We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RIS/PACS Software Receives CE Marking

By MedImaging International staff writers
Posted on 08 Oct 2012
A commercial version of the open source radiology information system/picture archiving and communication system (RIS/PACS) is designed to give medical practices a flexible, easy to use software solution, regardless of practice size and workflow complexities.

ClearCanvas, Inc. (Toronto, Canada), a medical imaging informatics company, recently received the European Community CE marking for its RIS/PACS software. “We are very excited about the potential the CE mark has created for ClearCanvas to build on its 25,000 strong user base,” commented Norman Young, CEO of ClearCanvas. “Efficient workflow is critical to the operational effectiveness of any clinical practice, so it’s important to provide a flexible, intuitive solution.”

The ClearCanvas RIS/PACS includes features such as personalized worklists, hanging protocols, and roaming user profiles while also offering more advanced functionality to empower practices worldwide.

ClearCanvas continues to advance its product range as it anticipates the ever-changing needs of medical imaging. Mr. Young noted, “My vision for ClearCanvas has always been to offer an integrated workflow solution to the medical imaging community that improves practice efficiency and enhances patient care.”

ClearCanvas is a worldwide provider of innovative and easy to use medical imaging solutions designed for radiology, specialty clinics, community hospitals and research facilities. ClearCanvas solutions include diagnostic workstations, PACS, and RIS.

Related Links:

ClearCanvas



X-ray Diagnostic System
FDX Visionary-A
Mammo DR Retrofit Solution
DR Retrofit Mammography
X-Ray Illuminator
X-Ray Viewbox Illuminators
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.